The harms to individuals, health-care systems and society from Canada’s opioid crisis are so grave that some physicians and lawyers are calling for criminal prosecution of OxyContin’s drugmaker.
As part of a Canada-wide settlement announced in May following a class-action lawsuit, Purdue Pharma (Canada) agreed to pay $20 million — including $2 million to provincial health plans — over how the company marketed and sold its pain medications OxyContin and OxyNEO.
Read more at CBC News